Today: 22 March 2026
Subscribe
Browse Category

Stock Market 12 January 2026

Robinhood (HOOD) stock jumps as bitcoin climbs; traders eye earnings and fresh scrutiny on event contracts

Robinhood (HOOD) stock jumps as bitcoin climbs; traders eye earnings and fresh scrutiny on event contracts

Robinhood shares rose 3.6% to $119.38 by late morning Monday, rebounding after an early drop. Bitcoin gained 1.2% to $92,046, while most crypto-linked stocks were steady. Investors are watching Robinhood’s Feb. 10 earnings and regulatory moves against sports event contracts, a sector the company is expanding into. Tennessee and Connecticut regulators have targeted several firms, including Robinhood, over unlicensed sports wagering.
12 January 2026
····
JPMorgan Chase stock slides as Trump’s 10% credit-card rate cap talk hits banks before earnings

JPMorgan Chase stock slides as Trump’s 10% credit-card rate cap talk hits banks before earnings

JPMorgan Chase shares dropped about 2% to $322.59 Monday after President Donald Trump called for a one-year 10% cap on credit card interest rates. Bank stocks broadly fell, with Citigroup down 3.7% and Capital One off 8%. Investors await JPMorgan’s quarterly results Tuesday for updates on consumer credit and card pricing. Trump’s proposal did not include details on enforcement.
12 January 2026
·
CoreWeave stock jumps 11% as Goldman starts coverage and Moody’s flags $3 trillion data-center boom

CoreWeave stock jumps 11% as Goldman starts coverage and Moody’s flags $3 trillion data-center boom

CoreWeave shares climbed 11% to $88.94 in late morning trading Monday after Goldman Sachs began coverage with a Neutral rating and $86 price target. Moody’s projected at least $3 trillion in data-center investment over five years, naming CoreWeave among six major U.S. operators. The Nasdaq 100 was little changed.
12 January 2026
·········
AST SpaceMobile stock slips in volatile trade as ASTS investors eye next launch steps and earnings

AST SpaceMobile stock slips in volatile trade as ASTS investors eye next launch steps and earnings

AST SpaceMobile shares fell 1.9% to $95.81 Monday after volatile trading, following the December launch of its BlueBird 6 satellite. Investors await the company’s quarterly results in March and updates on satellite deployment. AST aims to launch 45 to 60 satellites by the end of 2026. Other satellite connectivity stocks, including Globalstar and Iridium, rose modestly.
12 January 2026
··
Vistra stock jumps as VST taps debt markets; analysts recalibrate after Meta nuclear pact

Vistra stock jumps as VST taps debt markets; analysts recalibrate after Meta nuclear pact

Vistra shares rose about 5% Monday after announcing a private offering of senior secured notes maturing in 2031 and 2036. Proceeds will fund the Cogentrix acquisition and repay debt. The company recently signed 20-year nuclear power agreements with Meta for over 2,600 megawatts. Traders are watching note pricing ahead of Vistra’s Feb. 26 earnings report.
12 January 2026
··
Tesla stock rises in regular session as CPI looms and robotaxi deadlines return to focus

Tesla stock rises in regular session as CPI looms and robotaxi deadlines return to focus

Tesla shares rose 0.7% to $448.09 Monday as investors awaited Tuesday’s U.S. inflation report and the company’s Jan. 28 earnings release. Roughly 23.7 million shares traded by late morning. Tesla reported over 434,000 vehicles produced and 418,000 delivered in Q4. Wall Street remains focused on Fed rate moves and Tesla’s progress on autonomy targets.
12 January 2026
····
Revolution Medicines stock slips as Truist sticks to $99 target with Merck buyout talk in focus

Revolution Medicines stock slips as Truist sticks to $99 target with Merck buyout talk in focus

Revolution Medicines shares fell 1.8% to $116.51 in early Monday trading, retreating from last week’s highs after reports of ongoing Merck acquisition talks valuing the company at up to $32 billion. Truist maintained its Buy rating but kept its price target at $99, below the current price. Investors await the company’s presentation at the J.P. Morgan Healthcare Conference later Monday.
12 January 2026
··
Applied Digital (APLD) stock is up again — what’s driving the move after hyperscaler leases

Applied Digital (APLD) stock is up again — what’s driving the move after hyperscaler leases

Applied Digital shares rose about 2.5% to $38.61 in late-morning New York trading Monday, extending last week’s post-earnings rally. Investors are focused on leasing progress and funding for the company’s North Dakota AI data centers. The company recently reported $126.6 million in quarterly revenue, beating estimates, but posted a net loss of $31.2 million. Traders await new contract updates and Tuesday’s U.S. CPI report.
12 January 2026
··
Alphabet hits $4 trillion mark as Google’s AI reboot wins back Wall Street

Alphabet hits $4 trillion mark as Google’s AI reboot wins back Wall Street

Alphabet’s market value reached $4 trillion Monday, surpassing Apple and joining only three other companies at that level. Shares dipped 0.2% to $327.93 late morning after a 65% jump in 2025. Google Cloud revenue surged 34% in Q3, and Alphabet began leasing its in-house AI chips, with Meta reportedly in talks for a multi-billion dollar deal.
12 January 2026
···
AMD stock jumps as Bernstein stays cautious on chipmaker and Wall Street frets Fed fight

AMD stock jumps as Bernstein stays cautious on chipmaker and Wall Street frets Fed fight

AMD shares rose 2.6% to $208.44 by 10:31 a.m. EST Monday, outperforming a slightly lower Nasdaq 100. Analyst Stacy Rasgon kept AMD at “market perform,” citing Nvidia’s growing lead in AI chips. Nvidia was flat, Broadcom gained 1.9%, and Intel fell 1.1%. AMD reports quarterly results Feb. 3.
12 January 2026
········
Plug Power stock rises as UBS conference nears and Jan. 29 vote raises reverse-split stakes

Plug Power stock rises as UBS conference nears and Jan. 29 vote raises reverse-split stakes

Plug Power shares rose 4.1% to $2.28 Monday as investors focused on a Jan. 29 vote to double authorized shares to 3 billion. The company warned it will pursue a reverse stock split if the proposal fails. Last week, Plug amended a Walmart deal, removing the risk of diluting 42.2 million shares. Executives are scheduled to present at the UBS energy conference later today.
12 January 2026
··
Alphabet stock’s $4 trillion flashpoint: Google’s AI refocus puts it back in the lead

Alphabet stock’s $4 trillion flashpoint: Google’s AI refocus puts it back in the lead

Alphabet briefly topped a $4 trillion valuation Monday after unveiling a new AI strategy, before shares slipped 0.3% to $327.47 by late morning. Investors are watching Google Cloud’s expansion, early reviews of the Gemini 3 model, and efforts to rent out proprietary “Ironwood” AI chips. Reuters reported Meta may buy Alphabet’s chips for its data centers starting in 2027.
12 January 2026
···
Nvidia stock wobbles after $1B Eli Lilly AI lab plan as CPI and TSMC loom

Nvidia stock wobbles after $1B Eli Lilly AI lab plan as CPI and TSMC loom

Nvidia and Eli Lilly will invest $1 billion over five years in a joint research lab in the San Francisco Bay Area, aiming to use Nvidia’s new AI chips to accelerate drug discovery. Nvidia shares slipped 0.2% to $184.42 by 10:30 a.m. ET. Thermo Fisher Scientific will also collaborate with Nvidia on lab automation. The new site is expected to open by the end of March.
12 January 2026
····
1 … 533 534 535 536 537 … 1,358

Stock Market Today

  • CRISPR Therapeutics Stock Dips Amid Biotech Risks Despite Strong DCF Upside
    March 22, 2026, 2:39 AM EDT. CRISPR Therapeutics (CRSP) shares have fallen 14% year to date, contrasting with a 12.2% gain over the past year. The stock trades around $46.24, reflecting a 75.6% discount to its intrinsic value based on a Discounted Cash Flow (DCF) model projecting positive free cash flow by 2030. Despite short-term declines driven by biotech sector volatility and regulatory concerns, long-term growth potential linked to its gene-editing pipeline keeps investor interest. The company shows a $345.4 million free cash flow loss currently, moving to forecasted positive cash generation. Valuation metrics like price-to-book provide additional context amid earnings volatility. Market watchers may consider CRISPR's current weakness an opportunity, though risks remain given sector dynamics and cash flow uncertainty.
Go toTop